Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
Recruiting
N/A
Interventional Study
Infertility
in Vitro Fertilization (IVF)
ART
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 89
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 4,000 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The use of machine learning techniques using an artificial intelligence tool is proposed to analyze clinical data to predict best possible IVF/ART outcomes. This tool has been utilized to accurately predict embryo quality here at Cornell. Utilizing this tool to assess objective clinical findings and predict outcomes of assisted reproductive techniques is sought, with the ultimate goal of an automa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients undergoing ovarian stimulation (including OI and IVF cycles)
* Treatment for fresh embryo transfer and cryopreservation of oocytes or embryos upfront
* Healthy male partners of the female subjects who agree to be part of the study.
Exclusion Criteria:
* None
Contacts